← Leaderboards
Linda S Lloyd
Stress Therapeutics, Inc.
$3,759,254
Attributed
$3,759,254
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2019–25$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,759,254 · 5
By mechanism
R44$1,927,551 · 1
U43$999,393 · 1
R43$832,310 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Chronic”
- Jeffrey Reich · Sparian Biosciences, Inc.$21,671,295
- Priyamvada Acharya · Duke University$20,941,151
- Dale Sandler · Social And Scientific Systems, Inc.$18,360,118
- Steven Schachter · Massachusetts General Hospital$18,327,380
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Abraham Aizer Brody · New York University School Of Medicine$15,928,507
Research focus
ChronicBiological Adaptation To StressPharmaceutical PreparationsStressGlucocorticoidsAffinityMental DepressionNovel TherapeuticsHalf-LifeSmall Business Innovation Research GrantLeadPituitary GlandHypothalamic-Pituitary-Adrenal AxisDoseFoundationsMedicalDrug KineticsHypothalamic StructureInvestigational DrugsAntibodiesCorticotropin-Releasing HormoneFeedbackGlucocorticoid ReceptorAlzheimer&Apos
Grant awards (7)
Investigational New Drug (IND)-enabling Study for a New Therapeutic for Alcohol Use Disorder (AUD)$999,393
U43 · FY2025 · AA · contact PI
Novel therapeutic for HPA hyperactivity$716,742
R44 · FY2025 · AA · contact PI
Lead Optimization of a Therapeutic Candidate for Alzheimerâs Disease$349,605
R43 · FY2025 · AG · contact PI
Novel therapeutic for HPA hyperactivity$605,404
R44 · FY2024 · AA · contact PI
Novel therapeutic for HPA hyperactivity$605,405
R44 · FY2023 · AA · contact PI
Lead Optimization of Therapeutic Candidates for Alcohol Use Disorder (AUD)$257,731
R43 · FY2022 · AA · contact PI
Novel therapeutic for HPA hyperactivity$224,974
R43 · FY2019 · AA · contact PI